OBSEVA SA (OBSV)       0.2126  +0.01 (+2.56%)

0.2126  +0.01 (+2.56%)

CH0346177709 - Common Stock - After market: 0.2115 0 (-0.52%)

OBSEVA SA0.2126

NASDAQ:OBSV (1/27/2023, 7:25:41 PM)+0.01 (+2.56%)

After market: 0.2115 0 (-0.52%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS Sector Health Care
GICS Industry Biotechnology

Chartmill FA Rating
Valuation Growth
Profitability Health
Dividend

Overview
Earnings (Last) 12-01 2022-12-01/amc Earnings (Next) 03-06 2023-03-06
Ins Owners 2.48% Inst Owners 16.17%
Market Cap 17.96M Shares 84.50M
PE N/A Fwd PE N/A
Dividend Yield N/A Analysts 77.78
IPO 07-13 2018-07-13

Stock Screener Links

Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

OBSV Daily chart

Company Profile

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women's reproductive health and pregnancy. The company is headquartered in Plan-Les-Ouates, Geneve and currently employs 51 full-time employees. The company went IPO on 2018-07-13. The firm develops oral compounds to treat women’s reproductive health conditions from conception to birth. Its pipeline includes three product candidates: Linzagolix (OBE2109), an oral gonadotropin-releasing hormone (GnRH) receptor antagonist intended for the treatment of endometriosis and uterine fibroids; Nolasiban (OBE001), an oral oxytocin receptor antagonist, with the potential to inhibit uterine contractions at the time of embryo transfer, thereby enhancing embryo implantation during assisted reproductive technologies (ART), and OBE022, an oral and selective prostaglandin F2 alpha (PGF2a) receptor antagonist designed to control preterm labor.

Company Info

OBSEVA SA

Chemin des Aulx 12

Plan-les-Ouates GENEVE 1228

P: 41225521558.0

CEO: Brian O'Callaghan

Employees: 51

Website: http://www.obseva.com/

OBSV News

News Imagea month ago - ObsEva SAObsEva Announces Dismissal of Moratorium ProceedingsNews Imagea month ago - ObsEva SAObsEva Announces Dismissal of Moratorium Proceedings

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – December 19, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a...

News Image2 months ago - ObsEva SAObsEva Evidences Compliance with Nasdaq’s Stockholder’s Equity Rule and Announces Moratorium Dismissal Request FilingNews Image2 months ago - ObsEva SAObsEva Evidences Compliance with Nasdaq’s Stockholder’s Equity Rule and Announces Moratorium Dismissal Request Filing

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange   GENEVA, Switzerland – December 14, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a...

News Image2 months ago - Seeking AlphaOBSV stock falls on plans to raise share capital with new treasury stock (NASDAQ:OBSV)

ObsEva SA (OBSV) announced Friday that its board decided to increase the share capital through the issuance of newly registered shares in a bid to raise funds. Read the full story here.

News Image2 months ago - ObsEva SAObsEva To Increase Issued Share Capital by Creating Additional Treasury Shares

OBSV Twits

Here you can normally see the latest stock twits on OBSV, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example